Suchergebnisse - "Llorca, Pierre-Michel"

PubPharm (14)

1

Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults

enthalten in: Expert review of neurotherapeutics | 2024

von Samalin, L. | Boudieu, L. | Llorca, P.

2

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression

enthalten in: The New England journal of medicine | 2023

von Reif, A. | Bitter, I. | Buyze, J. | +114

CommentIn: N Engl J Med. 2024 Jan 4;390(1):93. - PMID 38169502

3

Combination of two long-acting injectable antipsychotics in treatment-resistant schizophrenia : A retrospective 12-month mirror-image study

enthalten in: Asian journal of psychiatry | 2023

von Calvin, N. | Minischetti, L. | Salanon, F. | +4

4

Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia

enthalten in: CNS drugs | 2021

von Kane, J. | McEvoy, J. | Correll, C. | +1

5

Predictive factors of functional remission in patients with early to mid-stage schizophrenia treated by long acting antipsychotics and the specific role of clinical remission

enthalten in: Psychiatry research | 2019

von Gorwood, P. | Bouju, S. | Deal, C. | +4

6

Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study

enthalten in: European psychiatry : the journal of the Association of European Psychiatrists | 2018

von Llorca, P. | Bobes, J. | Fleischhacker, W. | +7

7

Clinical Decision-Making in the Treatment of Schizophrenia : Focus on Long-Acting Injectable Antipsychotics

enthalten in: International journal of molecular sciences | 2016

von Samalin, L. | Garnier, M. | Auclair, C. | +1

8

Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation

enthalten in: Expert opinion on drug safety | 2016

von Samalin, L. | Garay, R. | Ameg, A. | +1

9

Comparison of olanzapine long-acting injection and oral olanzapine : a 2-year, randomized, open-label study in outpatients with schizophrenia

enthalten in: Journal of clinical psychopharmacology | 2014

von Detke, H. | Weiden, P. | Llorca, P. | +4

10

What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?

enthalten in: Nordic journal of psychiatry | 2014

von Samalin, L. | Nourry, A. | Charpeaud, T. | +1